Professional background

Gemma completed her medical degree (MBChB) at the University of Birmingham in 2004 and started her oncology training in 2008. Having attained FRCR in 2011, she completed her oncology training at UCLH then undertook a MD(Res) at University College London (UCL), which was awarded in 2016. She then took up a substantive consultant post at Imperial College NHS Healthcare Trust (ICHT), treating gynaecological and colorectal cancers, and was brachytherapy lead and unit training lead as well as honorary clinical senior lecturer at Imperial College London. To be able to focus on gynaecological cancers and brachytherapy, she returned to UCLH in 2017. 

Gemma specialises in the treatment of gynaecological cancers (focusing on cervical, endometrial, vulval and vaginal cancer) and the delivery of brachytherapy. She has a keen interest in complex targeted radiotherapy delivery using image guidance and adaptive techniques as well as the use of imaging biomarkers during chemo-radiotherapy.


Multiple book chapters including:

  • ‘Radiotherapy for uterine cervical cancer’, ‘Chemotherapy for Cervical cancer’, ‘Case 19: Head and Neck. Challenging Concepts in Oncology’, ‘Neoadjuvant Chemotherapy for Cervical Cancer’ and ‘Radiotherapy Treatment for Endometrial Cancer’Eminowicz G, Rompokos V, Stacey C, Hall L, McCormack M. Understanding the impact of pelvic organ motion on dose delivered to target volumes during IMRT for cervical cancer. Radiotherapy and Oncology 2017 Jan;122(1):116-121. doi:10.1016/j.radonc.2016.10.018.Epub 2016 Nov 16
  • Lemech CR, Ensell L, Paterson JC, Eminowicz G, Lowe H, Arora R, Arkenau HT, Widschwendter M, MacDonald N, Olaitan A, Mould T, Meyer T, Hartley J, Mitra A, Ledermann JA, McCormack M, Kristeleit RS. Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial Cancer. Oncology. 2016 Jun 3;91(1):48-54.
  • Eminowicz G, Motlib J, Khan S, Perna C, McCormack M. Pelvic Organ Motion during Radiotherapy for Cervical Cancer: Understanding Patterns and Recommended Patient Preparation. Clinical Oncology (R Coll Radiol). 2016 Sep;28(9):e85-91. doi: 10.1016/j.clon.2016.04.044.
  • Eminowicz G, Rompokos V, Stacey C, McCormack M. The dosimetric impact of target volume delineation variation for cervical cancer radiotherapy. Radiotherapy and Oncology 2016 Sep;120(3):493-499.
  • Eminowicz G, Hall-Craggs M, Diez P, McCormack M. Improving target volume delineation in intact cervical carcinoma: literature review and step-by-step pictorial atlas to aid contouring. Practical Radiation Oncology. 2016 6(5):e203-213. Doi 10.1016/j.prro.2016.01.006.
  • Eminowicz G, McCormack M. Variability of clinical target volume delineation for definitive radiotherapy in cervix cancer. Radiotherapy and Oncology 2015 Dec;117:542-547
  • Hoang Duc AK, Eminowicz G, Mendes R, Wong SL, McClelland J, Modat M, Cardoso MJ, Mendelson AF, Veiga C, Kadir T, D'Souza D, Ourselin S. Validation of clinical acceptability of an altas-based segmentation algorithm for the delineation of organs at risk in head and neck cancer. Medical Physics 2015 Sep;42(9):5027-34G
  • Eminowicz, C Dean, O Shoffren, N MacDougall, P Wells, R Muirhead. Intensity modulated radiotherapy (IMRT) to prostate and pelvic nodes; is pelvic lymph node coverage adequate with fiducial-based image guided radiotherapy? British Journal of Radiology May 2014;87(1037):20130696